regulation — Lanton Law Blog

The New York State Department of Financial Services has proposed new rules surrounding pharmacy benefit managers (PBMs) that deal with establishing definitions; licensing; contracting with pharmacies; acquisition of PBMs; consumer protections and audit regulations regarding PBMs.

healthcare, Medicare Part D, pharmaceuticals, pharmacy, pharmacy benefit managerRon LantonAugust 29, 2023Pharmacy Benefit Manager, New York, PBM, pharmacy, insurance, licensure, audit, contracting, mergers and acquisitions, regulation

Lanton Strategies: D.C. Based Lobbying Firm with No State Boundaries

COVID-19 has changed the way that we interact in a variety of ways. One of them being the way that businesses large and small interact with the government. Gone are the days where we can meet people in person without having to worry about travel restrictions and COVID-19 protocol. What remains is that businesses still need to get their voices heard. This is where Lanton Strategies has a strategic advantage.

5G, antitrust, agriculture, banking, biologics, Biosimilars, biotechnology, cannabis, CBD, Clean Energy, CMS, Congress, digital health, FDA, fintech, Green Energy, healthcare, HealthIT, HHS, life sciences, mobile health, pharmaceuticals, pharmacy, technology, telehealthRon LantonJanuary 28, 2021lobbyist, lobbying, legislation, regulation, regulatory, digital lobbying

Lanton Law Opens Cannabis Practice

Lanton Law believes that the cannabis market will continue to evolve and expand. Notwithstanding this market potential is the fact that medical and adult-use cannabis operations are confronted with a complex patchwork of state and federal laws and regulations that we assist a variety of businesses with.

cannabis, CBD, FDA, FTC, healthcare, banking, medical marijuana, pharmaceuticals, pharmacy, USDARon LantonOctober 9, 2020cannabis, CBD, marijuana, medical marijuana, regulation, dispensary, recreational marijuana, adult-use marijuana

Big Tech Company Executives Pressed On Capitol Hill On Their Market Influence

On July 29th four of the biggest tech companies, CEOs testified in front of Congress. Jeff Bezos of Amazon, Tim Cook of Apple, Mark Zuckerberg of Facebook, and Sundar Pichai of Google all took questions from the U.S House Judiciary Subcommittee on Antitrust, Commercial, and Administrative Law.